Maggie Chi · Parliamentary Secretary, Health Canada (HC)
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control.Read more
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control.Read more
Advocate for push and pull incentives to stimulate innovation in antimicrobials R&D and access, and incentives to encourage innovation in antimicrobial stewardship and antimicrobial alternatives. Promote a one-health approach to countering antimicrobial resistance.
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control.Read more
Advocate for push and pull incentives to stimulate innovation in antimicrobials R&D and access, and incentives to encourage innovation in antimicrobial stewardship and antimicrobial alternatives. Promote a one-health approach to countering antimicrobial resistance.
Sandenga Yerba · Director of Policy/Deputy Chief if Staff, Health Canada (HC)
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.